Skip to content
Telehealth Graded

Search Telehealth Graded

Use arrow keys or Tab to browse. Enter opens a result. Escape closes search.

Enter a name or topic to search.

State guide

Delaware's state employee plan and GLP-1s

If you're on Delaware's state employee health plan, GLP-1s for weight loss are still covered — and from July 1, 2026 they cost $200 a month at the counter. The minutes show the committee rejected a $132 copay first, by six votes to five.

Every source on this page was read first-hand in September 2026, and each one below carries the date printed on the document itself.

1
document cited
4
sourced facts
1
primary source

What changed, and what the document says

  1. What passed

    Conditions apply

    A flat $200 per 30-day supply, for the non-Medicare population, from July 1, 2026.

    “Secretary Gordon made a motion, which was seconded by Lt. Gov. Gay, to adopt Option 2, implementing a stand-alone copay of $200 per 30-day supply for weight loss GLP-1 medications, effective July 1, 2026, for the non-Medicare population.”

    State of Delaware, State Employee Benefits Committee — March 9, 2026

  2. What failed first

    Context

    A $132 copay, contingent on manufacturer assistance staying available. It lost on a named roll call before the $200 motion carried.

    “implement a stand-alone copay of $132 per month contingent upon the continued availability of the copay assistance program.”

    State of Delaware, State Employee Benefits Committee — March 9, 2026

  3. What was on the table

    Context

    Ending coverage entirely was one of the options the committee considered.

    “Mr. Stitzel reviewed several policy options for the Committee's consideration effective July 1, 2026, including eliminating coverage, implementing stand-alone or integrated copay structures of $120, $132 and $200, removing prior authorization requirements in exchange for enhanced rebate pricing, or maintaining the current copay structure.”

    State of Delaware, State Employee Benefits Committee — March 9, 2026

  4. What drove it

    Context

    Projected plan spending of about $92.1 million for the fiscal year, on a benefit that started in July 2023.

    “Mr. Stitzel reported that utilization and costs associated with GLP-1 medications for weight loss have increased significantly since the benefit was initially implemented in July 2023. Updated projections estimate gross plan spending of approximately $92.1 million for Fiscal Year 2026.”

    State of Delaware, State Employee Benefits Committee — March 9, 2026

Telehealth in Delaware

Some providers pay us a commission when you sign up through our links, at no extra cost to you.

Which of these companies serve Delaware?

Of the 284 companies we grade, 28 publish a list of the states they are licensed in. We checked 250 more and found no such list on any page we read; 6 we have not checked either way.

17 of those lists name Delaware: Gala Health, Care Bare Rx, Vita Bella, TelePeptide, Wisp, WePeptideRx, Ways2Well, TeleClinic, Tyde Wellness, Trimi, Enhance MD, HumeCare+, Rx.com, Mojoon, Peak Wellness, Sprout Health, and Allara Health. That is a licensure claim each company makes about itself, not something we checked with a state board.

A published list is a starting point, not a guarantee. If availability decides your choice, ask before you pay and get the answer in writing.

Coverage decides what you pay before cash does. See how state Medicaid programs cover GLP-1s and what a prior-authorization denial turns on.

Sources

Each document below was fetched and read on the date shown beside it, which is the date printed on the document — not always the date in its web address. All of them were read in September 2026.

Nothing on this page is medical advice, and nobody here is a clinician. Coverage rules change; check the linked document before you rely on it.